ATE328085T1 - Identifizierung und klonierung eines mycobakterien antigens der einer heparin- bindenden hemaglutinin entspricht - Google Patents

Identifizierung und klonierung eines mycobakterien antigens der einer heparin- bindenden hemaglutinin entspricht

Info

Publication number
ATE328085T1
ATE328085T1 AT97925109T AT97925109T ATE328085T1 AT E328085 T1 ATE328085 T1 AT E328085T1 AT 97925109 T AT97925109 T AT 97925109T AT 97925109 T AT97925109 T AT 97925109T AT E328085 T1 ATE328085 T1 AT E328085T1
Authority
AT
Austria
Prior art keywords
features
mycobacteria
adhesion
heparin
host cells
Prior art date
Application number
AT97925109T
Other languages
English (en)
Inventor
Franco Menozzi
Camille Locht
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE328085T1 publication Critical patent/ATE328085T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97925109T 1996-05-17 1997-05-20 Identifizierung und klonierung eines mycobakterien antigens der einer heparin- bindenden hemaglutinin entspricht ATE328085T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9606168A FR2748748B1 (fr) 1996-05-17 1996-05-17 Identification et clonage d'un antigene mycobacterien correspondant a une hemagglutine de liaison a l'heparine

Publications (1)

Publication Number Publication Date
ATE328085T1 true ATE328085T1 (de) 2006-06-15

Family

ID=9492234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925109T ATE328085T1 (de) 1996-05-17 1997-05-20 Identifizierung und klonierung eines mycobakterien antigens der einer heparin- bindenden hemaglutinin entspricht

Country Status (9)

Country Link
EP (1) EP0914437B1 (de)
AT (1) ATE328085T1 (de)
AU (1) AU3036297A (de)
DE (1) DE69736000T2 (de)
DK (1) DK0914437T3 (de)
ES (1) ES2267142T3 (de)
FR (1) FR2748748B1 (de)
PT (1) PT914437E (de)
WO (1) WO1997044463A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793492A1 (fr) * 1999-05-11 2000-11-17 Pasteur Institut Nouveau procede de purification par affinite
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
FR2832410B1 (fr) 2001-11-19 2004-04-02 Pasteur Institut Antigene mycobacterien recombinant de type hemagglutinine de liaison a l'heparine methylee, procedes de preparation et compositions immunogenes comprenant un tel antigene
WO2004009837A2 (en) * 2002-07-19 2004-01-29 Arizona Board Of Regents A high resolution typing system for pathogenic mycobacterium tuberculosum
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
WO2010149657A1 (en) 2009-06-22 2010-12-29 Px Therapeutics Method for the purification of hbha
WO2012038486A1 (en) 2010-09-21 2012-03-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method for obtaining a purified hbha polypeptide or fragment thereof
US20120321656A1 (en) * 2011-06-20 2012-12-20 Matthias Rath Oligopeptides and their use for treating infectious diseases
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
EP3551222B1 (de) 2016-12-07 2024-08-07 GlaxoSmithKline Biologicals SA Verfahren zur herstellung einer liposomzusammensetzung, die ein saponin umfasst
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
GB2600654B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel devices
WO2019106192A1 (en) 2017-12-01 2019-06-06 Glaxosmithkline Biologicals Sa Saponin purification
JP7640473B2 (ja) 2019-06-05 2025-03-05 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製

Also Published As

Publication number Publication date
AU3036297A (en) 1997-12-09
DE69736000D1 (de) 2006-07-06
EP0914437B1 (de) 2006-05-31
EP0914437A2 (de) 1999-05-12
ES2267142T3 (es) 2007-03-01
WO1997044463A2 (fr) 1997-11-27
DE69736000T2 (de) 2007-01-25
DK0914437T3 (da) 2006-10-02
FR2748748B1 (fr) 1998-11-06
FR2748748A1 (fr) 1997-11-21
PT914437E (pt) 2006-10-31
WO1997044463A3 (fr) 1998-01-29

Similar Documents

Publication Publication Date Title
DE69736000D1 (de) Identifizierung und klonierung eines mycobakterien antigens der einer heparin-bindenden hemaglutinin entspricht
Denis et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
BR9906927A (pt) Proteìnas de neisseria meningitidis
BR9408135A (pt) Produtos extra-celulares abundantes e processos para sua produção e uso
Grassmann et al. Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
Haanes et al. Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49
Simmons et al. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep
WO2001096368A3 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
WO2020065349A3 (en) Vaccines and methods
CA2759583A1 (en) A tuberculosis tb vaccine to prevent reactivation
JP2015536309A (ja) 結核菌（ｍ．ｔｕｂｅｒｃｕｌｏｓｉｓ）ワクチン
CA2523084A1 (en) Tuberculosis vaccine with improved efficacy
Fonseca et al. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein
Black et al. Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults
US20170043003A1 (en) New m.tuberculosis vaccines
Khademi et al. Mycobacterium tuberculosis HspX/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli
GB9409985D0 (en) Vaccine against mycobacterial infections
Rao et al. Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette–Guerin
BR9608894A (pt) Produtos extracelulares abundantes e processos para suas producões e usos
ATE161048T1 (de) Cdns sequenz des dengue virus serotype 1 (singapur stamm)
Wang et al. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice
CA2372583A1 (en) Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
US20060024332A1 (en) Recombinant ESAT-6:CFP-10 fusion protein useful for specific diagnosis of tuberculosis
BR0309491A (pt) Composição de vacina, composição imunogênica, utilização de uma proteìna e7 e anticorpos neutralizantes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0914437

Country of ref document: EP